Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The activated hepatic stellate cell (HSC) is central to liver fibrosis as the major source of collagens I and III and the tissue inhibitors of metalloproteinase-1 (TIMP-1). During spontaneous recovery from liver fibrosis, there is a decrease of TIMP expression, an increase in collagenase activity, and increased apoptosis of HSC, highlighting a potential role for TIMP-1 in HSC survival. In this report, we use tissue culture and in vivo models to demonstrate that TIMP-1 directly inhibits HSC apoptosis. TIMP-1 demonstrated a consistent, significant, and dose-dependent antiapoptotic effect for HSC activated in tissue culture and stimulated to undergo apoptosis by serum deprivation, cycloheximide exposure, and nerve growth factor stimulation. A nonfunctional mutated TIMP-1 (T2G mutant) in which all other domains are conserved did not inhibit apoptosis, indicating that inhibition of apoptosis was mediated through MMP inhibition. Synthetic MMP inhibitors also inhibited HSC apoptosis. Studies of experimental liver cirrhosis demonstrated that persistent expression of TIMP-1 mRNA determined by PCR correlated with persistence of activated HSC quantified by alpha smooth muscle actin staining, while in fibrosis, loss of activated HSC correlated with a reduction in TIMP-1 mRNA. We conclude that TIMP-1 inhibits apoptosis of activated HSC via MMP inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Concurrently, tissue inhibitors of metalloproteases (TIMPs) produced by HSCs are increased in experimental fibrosis, which could block the activity of their cognate enzymes and also prevent apoptosis of activated HSCs (278, 279).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [278]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Self-citationHepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Docherty, A. J. P., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J. R., Murphy, G., & Reynolds, J. J. (1985) · Nature · doi:10.1038/318066a0 · Cited by 689
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 666
Portmann, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80245-6 · Cited by 549
Baker, A. H., Zaltsman, A. B., George, S. J., & Newby, A. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1584 · Cited by 464
Research works printed but not linked: 6
- Milani, 1992, Hepatology, 16, 186
- Vyas, 1995, 5, 399
- Saile, 1997, Am. J. Pathol., 151, 1265
- Li, 1999, Cancer Res., 59, 6267
- Ree, 1997, Clin. Cancer Res., 3, 1623
- Trim, 2000, Hepatology, 32, 183
Cited by
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
“Moreover, matrix degradation in spontaneous recovery from fibrosis is associated with a loss of activated HSCs (33), which are known to be quantitatively the major source of matrix (9).”
BackgroundSelf-citationBrew, K., & Nagase, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.003 · Cited by 1,381
“While this effect of TIMP-1 on hepatic stellate cells was reported to be due to the inhibition of MMPs [90], the effects on other cells are not mediated by MMP inhibition [87–89].”
BackgroundSelf-citationLiver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Self-citationType 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2005) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,014
Self-citationCellular and molecular mechanisms in kidney fibrosis
Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 629
“TIMPs, on the other hand, have critical roles in regulating cell activity and survival (86–89).”
Fibroblast Differentiation in Wound Healing and Fibrosis
Darby, I. A., & Hewitson, T. D. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)57004-x · Cited by 600
Lambert, E., Dassé, E., Haye, B., & Petitfrère, E. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.008 · Cited by 541
“TIMP-1 [41,56].”
Backgroundde Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Apoptosis: The nexus of liver injury and fibrosis
Canbay, A., Friedman, S., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 527
Hemmann, S., Graf, J., Roderfeld, M., & Roeb, E. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.003 · Cited by 509
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
“A key determinant of fibrosis reversion is clearance of activated hepatic stellate cells through apoptosis, which requires downregulation of tissue inhibitor of metalloproteinase-1 (TIMP-1)”
BackgroundThe Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
Self-citationMatrix metalloproteinases in liver injury, repair and fibrosis
Duarte, S., Baber, J., Fujii, T., & Coito, A. J. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.004 · Cited by 476
Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D. A., Sands, E., Suliman, I., Trim, N., & Knorr, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.009 · Cited by 456
Self-citationThe role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · Apoptosis · doi:10.1007/s10495-005-1055-4 · Cited by 419
Novel functions of TIMPs in cell signaling
Chirco, R., Liu, X.-W., Jung, K.-K., & Kim, H.-R. C. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7893-x · Cited by 401
“second amino acid residue threonine for glycine in TIMP-1 (T2G TIMP-1 mutant), which confers selective MMP inhibition, was shown to obliterate its anti-apoptotic activity in activated hepatic stellate cells suggesting that the anti-apoptotic activity of TIMP-1 is dependent on MMP inhibition [70].”
BackgroundReversal of Hepatic Fibrosis — Fact or Fantasy?
Friedman, S. L., & Bansal, M. B. (2006) · Hepatology · doi:10.1002/hep.20974 · Cited by 379
Desmoulière, A., Darby, I. A., & Gabbiani, G. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000101911.53973.90 · Cited by 363
“Murphy et al (2002) have demonstrated that TIMP-1 directly inhibits hepatic stellate cell apoptosis via matrix metalloproteinase inhibition.”
BackgroundTsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Guo, L., Moss, S. E., Alexander, R. A., Ali, R. R., Fitzke, F. W., & Cordeiro, M. F. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0832 · Cited by 350
“Therefore, the increase in TIMP-1 may serve to counterbalance the simultaneous increase in MMP-9.(43) However, recent studies have shown that TIMP-1 has neuroprotective effects that are independent of its ability to inhibit MMPs.”
BackgroundFriedman, S. L. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.013 · Cited by 350
Hepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M., & Ciarmela, P. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx032 · Cited by 321
Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
Armstrong, T., Packham, G., Murphy, L. B., Bateman, A. C., Conti, J. A., Fine, D. R., Johnson, C. D., Benyon, R. C., & Iredale, J. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0825 · Cited by 317
“hydroxyproline, by methods described previously (18).”
Self-citationRies, C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1457-3 · Cited by 294
“TIMP-1 attenuation of apoptosis in activated hepatic stellate cells is dependent on MMP inhibition as demonstrated by utilization of non-MMP-inhibitory TIMP-1 mutants [70].”
Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B., Grant, L., Feirt, N., Seki, E., Brenner, D., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 289
Hepatic stellate cells and the reversal of fibrosis
Kisseleva, T., & Brenner, D. A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04584.x · Cited by 278
Liver fibrosis: cellular mechanisms of progression and resolution
Henderson, N. C., & Iredale, J. P. (2007) · Clinical Science · doi:10.1042/cs20060242 · Cited by 270
Self-citationExtracellular matrix degradation in liver fibrosis: Biochemistry and regulation
Iredale, J. P., Thompson, A., & Henderson, N. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.002 · Cited by 269
Self-citationPopov, Y., Patsenker, E., Fickert, P., Trauner, M., & Schuppan, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.025 · Cited by 268
“It occurs on the cell surface, requires complex formation with TIMP-2 and membrane-anchored MMP-14 [21], and the interaction of HSC/MF with hepatocytes [22].”
BackgroundInfluentialDecreased fibrosis during corticosteroid therapy of autoimmune hepatitis
Czaja, A. J., & Carpenter, H. A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.009 · Cited by 248
Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches
Mormone, E., George, J., & Nieto, N. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.07.001 · Cited by 246
“TIMP1 not only prevents the degradation of the rapidly increasing ECM by blocking MMPs, but also inhibits the apoptosis of activated HSC [75].”
BackgroundHepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved
Guyot, C., Lepreux, S., Combe, C., Doudnikoff, E., Bioulac-Sage, P., Balabaud, C., & Desmoulière, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.021 · Cited by 243
Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Arthur, M. J. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.33367 · Cited by 241
Self-citationConditional Ablation of Macrophages Halts Progression of Crescentic Glomerulonephritis
Duffield, J. S., Tipping, P. G., Kipari, T., Cailhier, J.-F., Clay, S., Lang, R., Bonventre, J. V., & Hughes, J. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61209-6 · Cited by 241
“TIMP-1 is a potent inhibitor of MMP activity such that there may be no collagenase activity in the presence of TIMP-1 expression even when tissue levels of MMP-13 are high.(43) Therefore these data suggest that regulation of TIMP-1 might represent a mechanism by which macrophage depletion ameliorates tissue fibrosis.”
BackgroundLipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Wobser, H., Dorn, C., Weiss, T. S., Amann, T., Bollheimer, C., Büttner, R., Schölmerich, J., & Hellerbrand, C. (2009) · Cell Research · doi:10.1038/cr.2009.73 · Cited by 238
Verbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236
Yoshiji, H. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00091-5 · Cited by 224
Engagement of αvβ3 Integrin Regulates Proliferation and Apoptosis of Hepatic Stellate Cells
Zhou, X., Murphy, F. R., Gehdu, N., Zhang, J., Iredale, J. P., & Benyon, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311668200 · Cited by 219
Self-citationSaxena, N. K., Titus, M. A., Ding, X., Floyd, J., Srinivasan, S., Sitaraman, S. V., & Anania, F. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1847fje · Cited by 212
A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis
Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan-Lluka, L. J., Ramm, G. A., & Mann, D. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050767 · Cited by 194
“We initially determined the ability of 5-HT2 receptor-selective antagonists to induce apoptosis by manual counting of acridine orange-stained cells as previously described.(4) Incubation of rat aHSCs with spiperone, LY53,857, and methiothepin induced elevated numbers of apoptotic aHSCs in a dose-dependent fashion (Fig…”
Parsons, C. J., Bradford, B. U., Pan, C. Q., Cheung, E., Schauer, M., Knorr, A., Krebs, B., Kraft, S., Zahn, S., Brocks, B., et al. (2004) · Hepatology · doi:10.1002/hep.20425 · Cited by 193
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
Canbay, A., Guicciardi, M. E., Higuchi, H., Feldstein, A., Bronk, S. F., Rydzewski, R., Taniai, M., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17740 · Cited by 193
Wang, X. M., Yu, D. M. T., McCaughan, G. W., & Gorrell, M. D. (2005) · Hepatology · doi:10.1002/hep.20853 · Cited by 193
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
Canbay, A., Guicciardi, M. E., Higuchi, H., Feldstein, A., Bronk, S. F., Rydzewski, R., Taniai, M., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317740 · Cited by 188
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183
“apoptotic properties (Murphy et al., 2002), and, by promoting”
BackgroundInfluentialCystathionine β Synthase Deficiency Promotes Oxidative Stress, Fibrosis, and Steatosis in Mice Liver
Robert, K., Nehmé, J., Bourdon, E., Pivert, G., Friguet, B., Delcayre, C., Delabar, J., & Janel, N. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.034 · Cited by 181
Liu, X.-W., Bernardo, M. M., Fridman, R., & Kim, H.-R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302999200 · Cited by 177
Gardner, J., & Ghorpade, A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10835 · Cited by 199
“In hepatic stellate cells, TIMP-1-mediated inhibition of apoptosis is through its effects on MMP (Murphy et al., 2002).”
BackgroundMolecular Serum Markers of Liver Fibrosis
Liu, T., Wang, X., Karsdal, M. A., Leeming, D. J., & Genovese, F. (2012) · Biomarker Insights · doi:10.4137/bmi.s10009 · Cited by 166
de Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706172 · Cited by 166
“In addition, secreted TIMP-1 has been shown to inhibit stellate cell apoptosis via inhibition of matrix metalloproteases (Murphy et al., 2002), suggesting that the lower number of activated HSC might be due to an increased apoptosis.”
BackgroundMolecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies
Li, J.-T., Liao, Z.-X., Ping, J., Xu, D., & Wang, H. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2180-y · Cited by 167
Novo, E., Marra, F., Zamara, E., Valfrè di Bonzo, L., Monitillo, L., Cannito, S., Petrai, I., Mazzocca, A., Bonacchi, A., De Franco, R. S. M., et al. (2006) · Gut · doi:10.1136/gut.2005.082701 · Cited by 168
Matrix metalloproteinase functions in hepatic injury and fibrosis
Roderfeld, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.011 · Cited by 163
Recognizing the Molecular Multifunctionality and Interactome of TIMP-1
Grünwald, B., Schoeps, B., & Krüger, A. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.08.006 · Cited by 161
Characteristic Expression Profiles Induced by Genotoxic Carcinogens in Rat Liver
Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W., & Ahr, H.-J. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh016 · Cited by 162
“Tissue inhibitor of metalloprotease 1 (Murphy et al., 2002), growth differentiation factor 15 (Subramaniam et al.”
BackgroundInfluentialMechanisms of alcohol‐induced hepatic fibrosis: A summary of the Ron Thurman Symposium†
Purohit, V., & Brenner, D. A. (2006) · Hepatology · doi:10.1002/hep.21107 · Cited by 161
Apoptosis and angiogenesis: an evolving mechanism for fibrosis
Johnson, A., & DiPietro, L. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-214189 · Cited by 160
The bright side of fibroblasts: molecular signature and regenerative cues in major organs
Gomes, R. N., Manuel, F., & Nascimento, D. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00153-z · Cited by 156
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
Herszényi, L., Hritz, I., Lakatos, G., Varga, M., & Tulassay, Z. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013240 · Cited by 158
Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside
Rockey, D. C., & Friedman, S. L. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.065 · Cited by 156
Matrix metalloproteinases, the pros and cons, in liver fibrosis
Han, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04586.x · Cited by 156
Perugorria, M. J., Latasa, M. U., Nicou, A., Cartagena‐Lirola, H., Castillo, J., Goñi, S., Vespasiani‐Gentilucci, U., Zagami, M. G., Lotersztajn, S., Prieto, J., et al. (2008) · Hepatology · doi:10.1002/hep.22437 · Cited by 151
Reversal of liver cirrhosis: current evidence and expectations
Jung, Y. K., & Yim, H. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.268 · Cited by 148
“TIMP1 not only prevents the degradation of the rapidly increasing ECM by blocking MMPs but also inhibits apoptosis of activated HSCs [58].”
BackgroundReversibility of liver fibrosis
Pellicoro, A., Ramachandran, P., & Iredale, J. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s26 · Cited by 135
“What are the features of cirrhosis that prevent successful remodelling? In animal models of cirrhosis, MMPs are present but their action is inhibited by high levels of TIMP-1 and to a lesser extent TIMP-2 [8-10].”
BackgroundSelf-citationInhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice
Roderfeld, M., Weiskirchen, R., Wagner, S., Berres, M., Henkel, C., Grötzinger, J., Gressner, A. M., Matern, S., & Roeb, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4828com · Cited by 133
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
Cruz-Munoz, W., & Khokha, R. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360801973244 · Cited by 131
“TIMP1 TG Inhibits Yes Inhibits stromelysin-1 induced apoptosis of alvelolar epithelial cells [206] rTIMP1 Inhibits No Inhibits apoptosis in BL cells in response to cold shock, serum starvation and fas activation [207] rTIMP1, TIMP1 vector Inhibits No Inhibits apoptosis of breast epithelial cells MCF10A, increases acti…”
Shimozono, R., Asaoka, Y., Yoshizawa, Y., Aoki, T., Noda, H., Yamada, M., Kaino, M., & Mochizuki, H. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084269 · Cited by 134
“TIMP-1, an inhibitor of ECM-degrading proteases, not only prevents the degradation of ECM but also inhibits the apoptosis of activated HSCs (Murphy et al., 2002), resulting in the synergistic induction of ECM synthesis.”
BackgroundThe therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
Dai, L., Li, H. Y., Guan, L.-X., Ritchie, G., & Zhou, J. X. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.07.005 · Cited by 131
“An in vitro study of Murphy et al. (2002) indicated that the inhibition of apoptosis of HSC by TIMP-1 is mediated via effects on MMP inhibition.”
BackgroundProgressive fibrosis during corticosteroid therapy of autoimmune hepatitis†
Czaja, A. J., & Carpenter, H. A. (2004) · Hepatology · doi:10.1002/hep.20235 · Cited by 127
“7 HLA DR3 /DR4 4/13 (31) 4/10 (40) 21/47 (45) HLA DR4 /DR3 4/13 (31) 2/10 (20) 17/47 (36) HLA DR3 /DR4 3/13 (23)* 3/10 (30)† 1/47 (2)*,† HLA DR3 /DR3 1/13 (8) 1/10 (10) 7/47 (15) HLA DR4 /DR4 0/13 (0) 0/5 (0) 4/47 (8)”
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells
Zamara, E., Novo, E., Marra, F., Gentilini, A., Romanelli, R. G., Caligiuri, A., Robino, G., Tamagno, E., Aragno, M., Danni, O., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00480-x · Cited by 123
Limb, G. A., Matter, K., Murphy, G., Cambrey, A. D., Bishop, P. N., Morris, G. E., & Khaw, P. T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62371-1 · Cited by 146
Kendall, T. J., Hennedige, S., Aucott, R. L., Hartland, S. N., Vernon, M. A., Benyon, R. C., & Iredale, J. P. (2009) · Hepatology · doi:10.1002/hep.22701 · Cited by 121
Self-citationChoi, J. S., Cho, W. L., Choi, Y. J., Kim, J. D., Park, H., Kim, S. Y., Park, J. H., Jo, D., & Cho, Y. W. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1565885 · Cited by 132
Liu, X.-W., Taube, M. E., Jung, K.-K., Dong, Z., Lee, Y. J., Roshy, S., Sloane, B. F., Fridman, R., & Kim, H.-R. C. (2005) · Cancer Research · doi:10.1158/0008-5472.898.65.3 · Cited by 119
“Whereas TIMP-1 inhibition of apoptosis was suggested to be dependent on its MMP-inhibitory activity in activated hepatic stellate cells (12, 13), emerging evidence indicated that the antiapoptotic activity of TIMP-1 is mediated by its activation of cell survival pathway independent of its MMP inhibitory activity in ot…”
BackgroundPark, J., Lee, J., Park, S. J., & Riew, K. D. (2005) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.00251 · Cited by 117
New Developments on the Treatment of Liver Fibrosis
Koyama, Y., Xu, J., Liu, X., & Brenner, D. A. (2016) · Digestive Diseases · doi:10.1159/000445269 · Cited by 117
Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis
Ruiz, V., Ordóñez, R. M., Berumen, J., Ramírez, R., Uhal, B., Becerril, C., Pardo, A., & Selman, M. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2003 · Cited by 118
“In addition to their inhibitory effects on MMPs, some of them show other properties, such as association with latent MMPs, cell growth-promotingactivity,cellsurvival-promotingactivity,andapoptosis (3, 15, 16, 29, 58).”
BackgroundMechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis
Chakraborty, J. B., Oakley, F., & Walsh, M. J. (2012) · International Journal of Hepatology · doi:10.1155/2012/648915 · Cited by 129
“In vitro treatment of HSCs with recombinant MMP9 stimulates apoptosis [79], which can be abrogated by pretreatment with an inhibitor [80].”
Tissue inhibitor of metalloproteinases-1 in breast cancer
Würtz, S. Ø., Schrohl, A.-S., Sørensen, N. M., Lademann, U., Christensen, I. J., Mouridsen, H., & Brünner, N. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00719 · Cited by 115
“This effect was shown to be dependent on the MMP inhibitory function of TIMP-1 since a mutated form of this protein possessing no MMP-inhibitory capacity was not able to exert the anti-apoptotic effect (Murphy et al. 2002).”
BackgroundMolecular basis of hepatic fibrosis
Hui, A. Y., & Friedman, S. L. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403005684 · Cited by 118
Tanwar, S., Trembling, P. M., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., Day, C. P., & Rosenberg, W. M. (2013) · Hepatology · doi:10.1002/hep.26030 · Cited by 114
Hepatocytes Express Nerve Growth Factor during Liver Injury
Oakley, F., Trim, N., Constandinou, C. M., Ye, W., Gray, A., Frantz, G. D., Hillan, K. J., Kendall, T. J., Benyon, R. C., Mann, D. A., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63544-4 · Cited by 113
Self-citationModulation of hepatic stellate cells and reversibility of hepatic fibrosis
Huang, Y., Deng, X., & Liang, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.038 · Cited by 122
Martinez, S. M., Fernández‐Varo, G., González, P., Sampson, E., Bruguera, M., Navasa, M., Jiménez, W., Sánchez‐Tapias, J. M., & Forns, X. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04500.x · Cited by 108
siRNA- and miRNA-based therapeutics for liver fibrosis
Zhao, Z., Lin, C.-Y., & Cheng, K. (2019) · Translational Research · doi:10.1016/j.trsl.2019.07.007 · Cited by 106
“The results showed that NLRC5 was overexpressed during liver fibrosis and increased the expression of a-SMA and Col1a in ARTICLE IN PRESS Translational Research 8 Zhao et al 2019 factor receptor 1 pathway regulates the activation of lipopolysaccharide‑induced HSCs. Fibroblast growth factor receptor 1-targeted siRNA de…”
BackgroundInfluentialWeiskirchen, R., Weiskirchen, S., & Tacke, F. (2018) · F1000Research · doi:10.12688/f1000research.14841.1 · Cited by 104
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
Katsarou, A., Moustakas, I. I., Pyrina, I., Lembessis, P., Koutsilieris, M., & Chatzigeorgiou, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i17.1993 · Cited by 115
Davaille, J., Li, L., Mallat, A., & Lotersztajn, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202798200 · Cited by 111
Reversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 98
“What are the features of cirrhosis that prevent successful remodelling? In animal models of cirrhosis, MMPs are present but their action is inhibited by high levels of TIMP-1 and to a lesser extent TIMP-2 [8-10].”
BackgroundSelf-citationBattle, T. E., Lynch, R. A., & Frank, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3612 · Cited by 108
Tang, J., Kang, Y., Huang, L., Wu, L., & Peng, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.015 · Cited by 114
Metadata
- Authors
- Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H.
- Affiliations
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Murphy, Frank R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11069-11076
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2164407945
- Cited by
- 432
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 9 · 2018: 18 · 2017: 12 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 19 · 2012: 20
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6800 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- TIMP-1, hepatic stellate cells, apoptosis, matrix metalloproteinase inhibition, liver fibrosis, liver cirrhosis, alpha-smooth muscle actin, collagenase, serum deprivation, cycloheximide, nerve growth factor, TIMP-1 mRNA expression
- MeSH terms
- Animals, Cell Division, Cells, Cultured, Cycloheximide, Humans, Liver, Liver Cirrhosis, Apoptosis, Tissue Inhibitor of Metalloproteinase-1, Caspases, In Situ Nick-End Labeling, Rats, Caspase 3, Matrix Metalloproteinase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.